Physician profile
Jeff Scott
NPI 1649245929
$1,963.12
in general payments reported to CMS, 2019-2025
20 companies · $66.22 in 2025
The $66.22 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $503 · 2021: $527 · 2022: $153 · 2023: $328 · 2025: $66.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $777.81 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $355.66 | 2019-2023 | Rebyota |
| Pfizer INC. | $199.34 | 2019-2021 | |
| Janssen Biotech, INC. | $89.31 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.61 | 2020-2021 | |
| Braintree Laboratories, INC. | $71.48 | 2020 | |
| Abiomed | $66.22 | 2025 | |
| Gilead Sciences, INC. | $59.76 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.07 | 2020-2021 | |
| Qol Medical, LLC | $37.75 | 2019-2021 | |
| Ucb, INC. | $36.17 | 2019 | |
| Daiichi Sankyo INC. | $32.40 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $18.07 | 2021 | |
| Genentech, INC. | $15.56 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.02 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $14.86 | 2020 | |
| Celgene Corporation | $12.67 | 2021 | |
| Redhill Biopharma INC. | $12.40 | 2020 | |
| Romark Laboratories, Lc | $9.49 | 2019 | |
| Daxor Corporation | $2.47 | 2023 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.